Skip to main content
. 2024 May 22;9(10):e174618. doi: 10.1172/jci.insight.174618

Table 1. In vitro and in vivo changes of MOC1 and MOC2 cancer after CX3CL1 overexpression.

graphic file with name jciinsight-9-174618-g037.jpg